Elevance Health (ELV) | Stock Overview & Key Data
Elevance Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $567.26 on September 2, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Elevance Health
ELV
|
76.43B Large-cap | -3.89% | 2.35% | 37.60% | 11.43% | 13.45% | 5.08% | -8.83% | 9.44% | 205.33% | 430.00% | 468.71% |
|
UnitedHealth
UNH
|
322.34B Mega-cap | 1.10% | 4.36% | 43.98% | 20.50% | 22.19% | 30.30% | -10.90% | 4.92% | 196.70% | 717.69% | 822.38% |
|
CVS Health
CVS
|
101.07B Large-cap | 3.71% | 5.00% | 32.75% | 26.34% | 25.65% | 51.14% | 50.56% | 23.74% | 7.51% | 173.13% | 237.73% |
|
Cigna
CI
|
72.68B Large-cap | 1.46% | 3.00% | 9.50% | 6.02% | 5.27% | -6.11% | 10.85% | 28.46% | 130.12% | 509.53% | 856.66% |
|
Humana
HUM
|
25.81B Large-cap | 6.82% | 24.63% | 123.70% | 38.41% | 43.78% | 61.19% | -14.91% | -10.46% | 102.63% | 389.25% | 653.77% |
|
Centene
CNC
|
20.21B Large-cap | -2.51% | 8.80% | 82.39% | 56.74% | 51.75% | 18.06% | -0.72% | -9.07% | 94.54% | 698.90% | 825.99% |
Ownership & Short Interest
Calculate Your Elevance Health Investment Returns
Long-Term Investment Performance Analysis
Elevance Health stock price in Jul 2016 was $142.94, A $1,000.00 lump sum investment in Elevance Health made 9 years ago would be worth approximately $2,811.60 today, representing a strong return of 181.16%. This translates to an annualized return (CAGR) of 11.00%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ELV's 52-week high and low?
- In the last 52 weeks, Elevance Health reached a high of $426.98 (on June 10, 2026) and a low of $273.71 (on August 6, 2025).
- What is the market cap and P/E ratio for ELV?
- Curious about Elevance Health's size and valuation? Its market capitalization stands at 76.43B. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.19, and the forward P/E (looking ahead) is 11.44.
- Does ELV pay dividends? If so, what's the yield?
- Yes, Elevance Health is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.36%, and the company has paid an average of $6.51 per share annually over the past 3 years.
- Who are Elevance Health's main competitors or similar companies to consider before investing?
When looking at Elevance Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UnitedHealth
UNH322.34B Healthcare Healthcare Plans 30.30% -10.90% CVS Health
CVS101.07B Healthcare Healthcare Plans 51.14% 50.56% Cigna
CI72.68B Healthcare Healthcare Plans -6.11% 10.85% Humana
HUM25.81B Healthcare Healthcare Plans 61.19% -14.91% Centene
CNC20.21B Healthcare Healthcare Plans 18.06% -0.72% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Elevance Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Elevance Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 13.25%, the Debt to Equity ratio from the most recent quarter is 74.39, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ELV?
- Looking at Elevance Health's growth, its revenue over the trailing twelve months (TTM) was $199B. Compared to the same quarter last year (YoY), quarterly revenue grew by 9.50%, and quarterly earnings saw a YoY growth of 30.90%.
- How much of ELV stock is held by insiders and institutions?
- Wondering who owns Elevance Health stock? Company insiders (like executives and directors) hold about 0.19% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 94.27%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.